Lung liquid biopsy: what to know

Blood contains small fragments of DNA released by cells. A laboratory can examine circulating tumour DNA for specific changes linked with a lung tumour. The result may help identify a treatment target, clarify a suspected change after treatment, or provide information when obtaining tissue is difficult.

A blood result is not the same as a complete diagnosis. The amount of tumour DNA in circulation can vary, and a test may not find a change that is present. A negative or incomplete result may therefore lead to a tissue biopsy, which examines cells from the tumour directly. Your clinician interprets the result alongside scans, symptoms, pathology, and previous treatment.

Usually, the sample is collected from a vein and sent to a specialist laboratory. Ask which test is being ordered, what changes it can detect, and how the result could alter treatment. Confirm whether the sample is being used for initial planning or to investigate a change during treatment. Keep copies of reports and ask how long interpretation may take. Do not change medicines because of a result without speaking with your oncology team.

The blood draw itself is generally brief, but tell the clinic if you feel faint, develop increasing redness or swelling at the puncture site, or have bleeding that does not settle with pressure. Seek urgent help for severe breathlessness, chest pain, coughing blood, sudden confusion, or a new seizure; these symptoms require clinical assessment rather than waiting for a laboratory report.

What decision will this test help us make? Which genes or tumour changes are included? If the result is negative, will I need a tissue biopsy? Could the result change later? When will we review it, and how will it fit with my scans and other pathology?